scholarly journals Effects of smoking cessation treatment attendance on abstinence: The moderating role of psychologically based behavioral health conditions

2020 ◽  
Vol 109 ◽  
pp. 1-7 ◽  
Author(s):  
Lorra Garey ◽  
Andrew H. Rogers ◽  
Kara Manning ◽  
Tanya Smit ◽  
Jaye L. Derrick ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Behavioral Health ◽  
Health Conditions ◽  
Smoking Cessation Treatment ◽  
Treatment Attendance ◽  
Cessation Treatment ◽  
Moderating Role

scholarly journals Smoking cessation treatment for COPD smokers: the role of counselling

2015 ◽  
Vol 79 (1) ◽  
Author(s):  
C.A. Jiménez-Ruiz ◽  
K.O. Fagerström
Keyword(s):  
Smoking Cessation ◽  
Weight Gain ◽  
Direct Relationship ◽  
Gain Control ◽  
Self Esteem ◽  
Smoking Cessation Treatment ◽  
Quit Attempt ◽  
Previous Diagnosis ◽  
Cessation Treatment

Smoking cessation is the only therapeutic intervention that can prevent COPD smokers from the chronic progression of their disorder. The most important intervention for helping these smokers to quit is a combination of counseling plus pharmacological treatment. The characteristics of the counseling should be different depending if this intervention is offered to smokers with a previous diagnosis of COPD or if the intervention is offered to smokers who have been recently diagnoses with COPD. The counseling of patients who have been recently diagnosed should include: a) explanation of the direct relationship between smoking and COPD, b) encouraging these patients to quit and c) using of spirometry and measurements of CO as a motivational tools. The counseling of patients who have been previously diagnosed should include: a) encouragement to make a serious quit attempt, b) an intervention that increases motivation, self-efficacy and self-esteem, c) and the intervention should also control depression and be directed to weight gain control.

scholarly journals Precision Preventive Medicine of Relapse in Smoking Cessation: Can MRI Inform the Search of Intermediate Phenotypes?

Biology ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. 35
Author(s):  
Yolaine Rabat ◽  
Sandra Chanraud ◽  
Majd Abdallah ◽  
Igor Sibon ◽  
Sylvie Berthoz
Keyword(s):  
Smoking Cessation ◽  
Meta Analysis ◽  
Major Health Problem ◽  
Major Health ◽  
Smoking Cessation Treatment ◽  
Intermediate Phenotypes ◽  
Prevention Therapy ◽  
Cessation Treatment ◽  
Magnetic Resonance Imaging Mri

Chronic tobacco smoking remains a major health problem worldwide. Numerous smokers wish to quit but most fail, even if they are helped. The possibility of identifying neuro-biomarkers in smokers at high risk of relapse could be of incredible progress toward personalized prevention therapy. Our aim is to provide a scoping review of this research topic in the field of Magnetic Resonance Imaging (MRI) and to review the studies that investigated if MRI defined markers predicted smoking cessation treatment outcome (abstainers versus relapsers). Based on the available literature, a meta-analysis could not be conducted. We thus provide an overview of the results obtained and take stock of methodological issues that will need to be addressed to pave the way toward precision medicine. Based on the most consistent findings, we discuss the pivotal role of the insula in light of the most recent neurocognitive models of addiction.

scholarly journals Smoking cessation treatment for COPD smokers: the role of pharmacological interventions

2015 ◽  
Vol 79 (1) ◽  
Author(s):  
C.A. Jiménez-Ruiz ◽  
K.O. Fagerström
Keyword(s):  
Smoking Cessation ◽  
Replacement Therapy ◽  
Nicotine Replacement Therapy ◽  
Cost Effective ◽  
Pharmacological Treatments ◽  
Pharmacological Interventions ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment ◽  
High Doses

Because stopping smoking is such a pressing necessity for COPD smokers physicians should use smoking cessation treatments aggressively. For optimal efficacy smoking cessation in COPD smokers should combine behavioral and pharmacological treatments. Three types of pharmacological treatments are proven to be safe and effective: Nicotine Replacement Therapy (NRT), Bupropion and Varenicline. Use of NRT, bupropion or varenicline, single or in combination, at standard doses or at high doses, for 8-12 weeks or for more than 6-12 months have proven to help these patients to quit. For optimizing efficacy these medications can also be introduced some weeks before actual quitting. In COPD smoking patients that are not interested in stopping completely or abruptly these medications can be used to aid cessation in a more gradual way. Pharmacotherapy to aid cessation in COPD smokers have proven to be highly cost effective.

Nature and Role of Change in Anxiety Sensitivity During NRT-Aided Cognitive-Behavioral Smoking Cessation Treatment

2012 ◽  
Vol 41 (1) ◽  
pp. 51-62 ◽  
Author(s):  
Yaara Assayag ◽  
Amit Bernstein ◽  
Michael J. Zvolensky ◽  
Dan Steeves ◽  
Sherry S. Stewart
Keyword(s):  
Smoking Cessation ◽  
Anxiety Sensitivity ◽  
Cognitive Behavioral ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment

scholarly journals History of smoking cessation treatment in Poland – the strengthening role of cytisine as the most effective and safe pharmacotherapy

2020 ◽  
Vol 6 (2) ◽  
pp. 116-123
Author(s):  
Witold Zatoński ◽  
Kinga Janik-Koncewicz ◽  
Zuzanna Stępnicka ◽  
Katarzyna Zatońska ◽  
Katarzyna Połtyn-Zaradna ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment ◽  
History Of

scholarly journals Predicting Engagement in Smoking Cessation Treatment Following a Brief Telephone Evaluation and Referral Session

2018 ◽  
Vol 14 (2) ◽  
pp. 125-131 ◽  
Author(s):  
Angela Petersen ◽  
Suraya Jabaiah ◽  
Timothy Chen ◽  
Neal Doran ◽  
Mark Myers
Keyword(s):  
Smoking Cessation ◽  
Chart Review ◽  
Treatment Engagement ◽  
Treatment Utilization ◽  
Telephone Contact ◽  
Smoking Cessation Treatment ◽  
Treatment Attendance ◽  
Us Military ◽  
Cessation Treatment ◽  
Hispanic White

Introduction: Smoking cessation treatment combining medication and counselling yields the best outcomes; however, few smokers employ both modalities.Aims: The purpose of this study was to examine variables predicting treatment attendance.Methods: This was a chart review of US military Veterans (N = 340; 89% male, 59% non-Hispanic white) referred for smoking cessation, who completed a telephone call to encourage treatment utilization. Treatment engagement was defined as attending a smoking cessation session within 30 days following telephone contact. A logistic regression analysis examined predictors (demographics, smoking variables, and psychiatric diagnoses) of treatment engagement.Results/Findings: Greater age (Odds Ratio [OR] = 1.04, 95% confidence interval [CI] 1.01–1.06), more cigarettes (OR = 1.03, 95% CI 1.00–1.06), and higher perceived importance of quitting (OR = 1.11, 95% CI 1.00–1.23) predicted engaging in treatment within 30 days (all p values < 0.05).Conclusion: Veterans who attended treatment were older, smoked more cigarettes, and perceived quitting as more important than those who did not attend. These findings are consistent with prior studies examining factors associated with treatment utilization. Results highlight the need to identify strategies for engaging into treatment smokers who are younger, smoke fewer cigarettes, and view quitting as less important.

Effect of BMI on Prolonged Abstinence after Smoking Cessation Treatment: A Retrospective Cohort Study

2021 ◽  
Vol 13 ◽  
Author(s):  
Fernanda Piotto Frallonardo ◽  
Danielle Ruiz Lima ◽  
Carlos Felipe Cavalcanti Carvalho ◽  
Aline Rodrigues Loreto ◽  
Bruna Beatriz Sales Guimarães-Pereira ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Cohort Study ◽  
Regression Models ◽  
Overweight And Obesity ◽  
Baseline Body Mass Index ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment ◽  
Baseline Bmi ◽  
Prolonged Abstinence

Background: Despite the well-documented relationship between weight gain and poorer cessation outcomes among smokers, the role of the former (baseline) weight in smoking cessation is insufficiently investigated. We hypothesized that patients with higher baseline body mass index(BMI) have a worse prognosis in tobacco cessation. Objectives: This retrospective clinical cohort study aimed to investigate the role of the baseline BMI on abstinence over 12 months after participation in smoking cessation treatment conducted in a middle-income country (n = 664). Methods: Data from a 6-week smoking cessation protocol performed in a Psychosocial Care Unit(CAPS) were used. The protocol included four medical consultations and six Cognitive-Behavioral Therapy(CBT) group sessions. Initially, 1,213 participants were evaluated for the study, but only the participants whose telephone contact was successful were included in the outcome analyses. The attrition rate was 45.3%. Continuous and categorical (normal, overweight, and obesity) BMI values were computed. Survival regression models were used to test the associations between BMI and the 12-month abstinence outcome. Self-report 4-week abstinence at the end of treatment was also investigated using logistic regression models. Results: Baseline BMI had no significant effect on both short (4-week-point abstinence) and long (12-month prolonged abstinence) treatment outcomes. Conclusion: The possible influence of the baseline BMI on smoking cessation outcomes, especially considering prolonged abstinence, was not corroborated by our results. Regardless of our results, the detrimental health outcomes due to the combination of obesity/overweight and smoking justify that these subgroups of individuals be continuously targeted for adequate smoking prevention and treatment.

scholarly journals Results from a Community-Based Smoking Cessation Treatment Program for LGBT Smokers

2013 ◽  
Vol 2013 ◽  
pp. 1-9 ◽  
Author(s):  
Alicia K. Matthews ◽  
Chien-Ching Li ◽  
Lisa M. Kuhns ◽  
Timothy B. Tasker ◽  
John A. Cesario
Keyword(s):  
Smoking Cessation ◽  
Treatment Program ◽  
Community Outreach ◽  
Future Research ◽  
Community Based ◽  
Smoking Cessation Treatment ◽  
Treatment Attendance ◽  
Culturally Tailored ◽  
Cessation Treatment ◽  
Higher Educational Attainment

Introduction. Little is known about lesbian, gay, bisexual, and transgender (LGBT) people’s response to smoking cessation interventions. This descriptive study examined the benefits of a community-based, culturally tailored smoking cessation treatment program for LGBT smokers.Methods. A total ofN=198LGBT individuals recruited from clinical practice and community outreach participated in group-based treatment. Sessions were based on the American Lung Association’s “Freedom from Smoking Program” (ALA-FFS) and were tailored to LGBT smokers’ needs. Seven-day smoking point prevalence abstinence served as the primary outcome.Results. Participants (Mage = 40.5) were mostly White (70.4%) and male (60.5%) and had at least a college degree (58.4%). Forty-four percent scored in the moderate range on the Fagerström Test for Nicotine Dependence pretreatment, and 42.4% completed treatment (≥75% sessions). Higher educational attainment and use of nicotine replacement therapy (NRT) were associated with treatment completion. Self-reported quit rates were 32.3% at posttreatment assessment. Treatment attendance (OR = 2.45), use of NRT (OR = 4.24), and lower nicotine dependency (OR = 0.73) were positively associated with quitting smoking.Conclusions. Results suggest the benefits of offering LGBT smokers culturally tailored smoking cessation treatments. Future research could improve outcomes by encouraging treatment attendance and promoting NRT uptake.

Sign in / Sign up

Export Citation Format

Share Document